[Neurotoxicity of antiepileptic drugs].
Yagi
K
K
Watanabe
M
M
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000493:pharmacokinetics; D001569:Benzodiazepines / Q000009:adverse effects; D002220:Carbamazepine / Q000009:adverse effects; D002648:Child; D005013:Ethosuximide / Q000009:adverse effects; D006801:Humans; D008297:Male; D009420:Nervous System / Q000187:drug effects* / Q000378:metabolism; D009422:Nervous System Diseases / Q000139:chemically induced*; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011324:Primidone / Q000009:adverse effects; D014635:Valproic Acid / Q000009:adverse effects
D000927:Anticonvulsants; D001569:Benzodiazepines; D011324:Primidone; D002220:Carbamazepine; D005013:Ethosuximide; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital